PEDIATRICS Vol. 92 No. 3 September 1993, pp. 461-463
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIBAN, P.
Right arrow Articles by ZACCHELLO, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIBAN, P.
Right arrow Articles by ZACCHELLO, F.

Adverse Effect of Chloral Hydrate in Two Young Children With Obstructive Sleep Apnea

PAOLO BIBAN MD1, EUGENIO BARALDI MD1, ANDREA PETTEENAZZO MD1, MARCO FILIPPONE MD1, and FRANCO ZACCHELLO MD1

1 Dept of Pediatrics, University of Padova, Padova, Italy

For many years chloral hydrate (CH) has been considered a safe and effective drug for sedation in infants and young children,1 and it is widely used in patients undergoing various diagnostic procedures, such as magnetic resonance imaging, electroencephalography, ultrasonography, lung function testing, and many others.1-6 The recommended doses range from 30 to 100 mg/kg.7,8

However, Hershenson et al9 have described a near-fatal respiratory arrest in a child after administration of CH, raising some concerns about possible risks in using this drug for sedation in infants or children with obstructive sleep apnea (OSA).

We report two cases of respiratory failure in two 24-month-old children with suspected OSA, who did need bag ventilation after oral sedation with CH (80 mg/kg) during lung function studies.

Submitted on January 28, 1993
Accepted on March 26, 1993




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
L Whiteford, P Fleming, and A J Henderson
Who should have a sleep study for sleep related breathing disorders?
Arch. Dis. Child., September 1, 2004; 89(9): 851 - 855.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. J. Coté, H. W. Karl, D. A. Notterman, J. A. Weinberg, and C. McCloskey
Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation
Pediatrics, October 1, 2000; 106(4): 633 - 644.
[Abstract] [Full Text]

Home page
 Anesth. Analg.Home page
S. G. Strauss, A. M. Lynn, S. L. Bratton, and M. K. Nespeca
Ventilatory Response to CO2 in Children with Obstructive Sleep Apnea from Adenotonsillar Hypertrophy
Anesth. Analg., August 1, 1999; 89(2): 328 - 328.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. H. Hertzog, J. K. Campbell, H. J. Dalton, and G. J. Hauser
Propofol Anesthesia for Invasive Procedures in Ambulatory and Hospitalized Children: Experience in the Pediatric Intensive Care Unit
Pediatrics, March 1, 1999; 103(3): 30e - 30.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
K. A. Waters, F. McBrien, P. Stewart, M. Hinder, and S. Wharton
Effects of OSA, inhalational anesthesia, and fentanyl on the airway and ventilation of children
J Appl Physiol, May 1, 2002; 92(5): 1987 - 1994.
[Abstract] [Full Text] [PDF]